FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102617513> ?p ?o ?g. }

• W2102617513 abstract "Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system with a disabling progressive course. Chronic cerebrospinal venous insufficiency (CCSVI) has recently been described as a vascular condition characterized by restricted venous outflow from the brain, mainly due to blockages of the internal jugular and azygos veins. Despite a wide variability among studies, it has been found to be associated with MS. Data from a few small case series suggest possible improvement of the clinical course and quality of life by performing percutaneous balloon angioplasty (PTA) of the stenotic veins. This is a multicenter, randomized, parallel group, blinded, sham-controlled trial to assess the efficacy and safety of PTA. Participants with relapsing remitting MS or secondary progressive MS and a sonographic diagnosis of CCSVI will be enrolled after providing their informed consent. Each participant will be centrally randomized to receive catheter venography and PTA or catheter venography and sham PTA. Two primary end points with respect to efficacy at 12 months are (1) a combined end point obtained through the integration of five functional indicators, walking, balance, manual dexterity, bladder control, and visual acuity, objectively measured by instruments; and (2) number of new brain lesions measured by T2-weighted MRI sequences. Secondary end points include annual relapse rate, change in Expanded Disability Status Scale score, proportion of patients with zero, one or two, or more than two relapses; fatigue; anxiety and depression; general cognitive state; memory/attention/calculus; impact of bladder incontinence; and adverse events. Six hundred seventy-nine patients will be recruited. The follow-up is scheduled at 12 months. Patients, treating neurologists, trained outcome assessors, and the statistician in charge of data analysis will be masked to the assigned treatment. The study will provide an answer regarding the efficacy of PTA on patients’ functional disability in balance, motor, sensory, visual and bladder function, cognitive status, and emotional status, which are meaningful clinical outcomes, beyond investigating the effects on inflammation. In fact, an important part of patients’ expectations, sustained and amplified by anecdotal data, has to do precisely with these functional aspects. Clinicaltrials.gov NCT01371760" @default.
• W2102617513 created "2016-06-24" @default.
• W2102617513 creator A5004761866 @default.
• W2102617513 creator A5011959155 @default.
• W2102617513 creator A5016597149 @default.
• W2102617513 creator A5018281423 @default.
• W2102617513 creator A5020192894 @default.
• W2102617513 creator A5026458697 @default.
• W2102617513 creator A5035404137 @default.
• W2102617513 creator A5035543933 @default.
• W2102617513 creator A5036597704 @default.
• W2102617513 creator A5036614366 @default.
• W2102617513 creator A5047825505 @default.
• W2102617513 creator A5050669429 @default.
• W2102617513 creator A5062167500 @default.
• W2102617513 creator A5071494198 @default.
• W2102617513 creator A5075852923 @default.
• W2102617513 creator A5077670419 @default.
• W2102617513 creator A5078095156 @default.
• W2102617513 creator A5083575870 @default.
• W2102617513 date "2012-10-03" @default.
• W2102617513 modified "2023-09-27" @default.
• W2102617513 title "Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial" @default.
• W2102617513 cites W1482522726 @default.
• W2102617513 cites W1491537345 @default.
• W2102617513 cites W1657604788 @default.
• W2102617513 cites W1902634523 @default.
• W2102617513 cites W1934342468 @default.
• W2102617513 cites W1954349838 @default.
• W2102617513 cites W1964264880 @default.
• W2102617513 cites W1975104912 @default.
• W2102617513 cites W1994476850 @default.
• W2102617513 cites W1995649794 @default.
• W2102617513 cites W2008199441 @default.
• W2102617513 cites W2014915708 @default.
• W2102617513 cites W2022808661 @default.
• W2102617513 cites W2033236084 @default.
• W2102617513 cites W2035282943 @default.
• W2102617513 cites W2044022462 @default.
• W2102617513 cites W2056132292 @default.
• W2102617513 cites W2066987163 @default.
• W2102617513 cites W2070532347 @default.
• W2102617513 cites W2071990331 @default.
• W2102617513 cites W2077126096 @default.
• W2102617513 cites W2084412126 @default.
• W2102617513 cites W2085526231 @default.
• W2102617513 cites W2087589796 @default.
• W2102617513 cites W2100406223 @default.
• W2102617513 cites W2103758700 @default.
• W2102617513 cites W2107128347 @default.
• W2102617513 cites W2107422246 @default.
• W2102617513 cites W2107783338 @default.
• W2102617513 cites W2109104731 @default.
• W2102617513 cites W2112165124 @default.
• W2102617513 cites W2112567923 @default.
• W2102617513 cites W2114728329 @default.
• W2102617513 cites W2117059621 @default.
• W2102617513 cites W2121439646 @default.
• W2102617513 cites W2121572293 @default.
• W2102617513 cites W2122319184 @default.
• W2102617513 cites W2129175650 @default.
• W2102617513 cites W2130075988 @default.
• W2102617513 cites W2131682620 @default.
• W2102617513 cites W2131709112 @default.
• W2102617513 cites W2136078048 @default.
• W2102617513 cites W2151340435 @default.
• W2102617513 cites W2155030120 @default.
• W2102617513 cites W2164728593 @default.
• W2102617513 cites W2165758561 @default.
• W2102617513 cites W2327531415 @default.
• W2102617513 cites W2916040650 @default.
• W2102617513 cites W4235232173 @default.
• W2102617513 cites W4238002937 @default.
• W2102617513 cites W4254694231 @default.
• W2102617513 doi "https://doi.org/10.1186/1745-6215-13-183" @default.
• W2102617513 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3567958" @default.
• W2102617513 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23034121" @default.
• W2102617513 hasPublicationYear "2012" @default.
• W2102617513 type Work @default.
• W2102617513 sameAs 2102617513 @default.
• W2102617513 citedByCount "20" @default.
• W2102617513 countsByYear W21026175132012 @default.
• W2102617513 countsByYear W21026175132013 @default.
• W2102617513 countsByYear W21026175132014 @default.
• W2102617513 countsByYear W21026175132015 @default.
• W2102617513 countsByYear W21026175132017 @default.
• W2102617513 countsByYear W21026175132018 @default.
• W2102617513 countsByYear W21026175132019 @default.
• W2102617513 countsByYear W21026175132022 @default.
• W2102617513 crossrefType "journal-article" @default.
• W2102617513 hasAuthorship W2102617513A5004761866 @default.
• W2102617513 hasAuthorship W2102617513A5011959155 @default.
• W2102617513 hasAuthorship W2102617513A5016597149 @default.
• W2102617513 hasAuthorship W2102617513A5018281423 @default.
• W2102617513 hasAuthorship W2102617513A5020192894 @default.
• W2102617513 hasAuthorship W2102617513A5026458697 @default.
• W2102617513 hasAuthorship W2102617513A5035404137 @default.
• W2102617513 hasAuthorship W2102617513A5035543933 @default.
• W2102617513 hasAuthorship W2102617513A5036597704 @default.
• W2102617513 hasAuthorship W2102617513A5036614366 @default.

• next